Mapi Pharma to Host a Key Opinion Leader Webinar on
GA Depot is a Potential Long Acting Injection Solution for Multiple Sclerosis Patients Positive Results from Phase III GA Depot Study in Relapsing MS to...
Source: globenewswire.com
Stay updated with breaking news from Multiple Sclerosis Care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GA Depot is a Potential Long Acting Injection Solution for Multiple Sclerosis Patients Positive Results from Phase III GA Depot Study in Relapsing MS to...
Although some repletion of B cells occurs with the B-cell depleting MS drug ocrelizumab, the effect does not appear to be associated with symptom worsening or a 'wearing off' effect.